Emerging Drugs for GPP

CE / CME

New and Emerging Drug Therapies for Generalized Pustular Psoriasis

ABIM MOC: maximum of 0.25 Medical Knowledge MOC point

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

Nurses: 0.25 Nursing contact hour

Physicians: maximum of 0.25 AMA PRA Category 1 Credit

Pharmacists: 0.25 contact hour (0.025 CEUs)

Released: October 05, 2023

Expiration: October 04, 2024

Boni Elewski
Boni Elewski, MD

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

Marie is a 43-year-old patient who presents to the ED with moderate to severe generalized pustular psoriasis. Which of the following agents received FDA approval as a Breakthrough Therapy based on efficacy and safety results from a phase II trial?